Thanks, the 2% discount is mentioned here as well: http://www.biocentury.com/dailynews/company/2014-01-29/teva-prices-thrice-weekly-copaxone Too small discount to encourage patient conversion, guess the main strategy is statments like the one made by Prof. Khan.